The stock is in a pronounced downtrend from its recent highs, having declined 20.90% over the past three months and 6.00% over the last six months, despite a strong 106.48% gain over the past year. Currently trading at $27.40, the price sits approximately 36% above its 52-week low of $12.58 but 33% below its 52-week high of $41.14, indicating it is in the lower-middle portion of its annual range and has surrendered a significant portion of its prior gains. Recent momentum shows a sharp divergence, with a strong 13.93% gain over the past month suggesting a potential short-term rebound or relief rally, yet this positive move is occurring within the context of a broader multi-month decline, signaling high volatility and a lack of clear directional conviction. Key technical support is anchored at the 52-week low of $12.58, while immediate overhead resistance resides near the 52-week high of $41.14; a sustained break above the recent downtrend channel would be needed to signal a reversal, while a breakdown below $24 could accelerate selling. The stock's beta of 0.34 indicates it has been significantly less volatile than the broader market, which is unusual for a commodity stock but may reflect its recent trading range, though the 40.86% max drawdown highlights the substantial peak-to-trough risk inherent in the name.

Revenue growth has turned negative, with Q4 2025 revenue of $1.02 billion representing an 8.98% year-over-year decline, and the multi-quarter trend shows significant volatility, moving from strong profitability in early 2024 to recent quarters of contraction. The company's profitability is highly inconsistent, as evidenced by a net income of $10.4 million in Q4 2025 following a net loss of $70.1 million in Q3 2025, with gross margins compressing sharply to 4.86% in the latest quarter from levels above 22% in mid-2024, indicating severe pressure on pricing or costs. Financially, the balance sheet appears robust with a low debt-to-equity ratio of 0.14 and a strong current ratio of 1.85, while the company generated positive free cash flow of $223.4 million on a trailing twelve-month basis, providing internal funding flexibility; however, the negative return on equity of -1.50% and return on assets of -0.72% reflect the current period's weak earnings power.